M. Goodmanson

Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2.

D. Tindall, R. Wolfert, G. Klee, 1999, Clinical chemistry.

Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.

D. Tindall, G. Klee, C. Young, 1997, Cancer research.

Mass spectrometry measurements of prostate-specific antigen (PSA) peptides derived from immune-extracted PSA provide a potential strategy for harmonizing immunoassay differences.

N. Anderson, Ravinder J. Singh, E. Klee, 2014, American journal of clinical pathology.

Serum concentrations of prostate-specific antigen measured using immune extraction, trypsin digestion, and tandem mass spectrometry quantification of LSEPAELTDAVK peptide.

N. Anderson, E. Bergstralh, Ravinder J. Singh, 2014, Archives of pathology & laboratory medicine.

Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry.

George G Klee, David C Muddiman, D. Muddiman, 2004, Journal of proteome research.

Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood.

H. R. Bergen, T. Sebo, E. Bergstralh, 2012, Clinical chemistry.

Development of a dual monoclonal antibody immunoassay for total human kallikrein 2.

G. Klee, S. Mikolajczyk, H. Rittenhouse, 2001, Clinical chemistry.